BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 228988)

  • 1. Inhibitors of kininases.
    Erdös EG
    Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protaminase activity of plasma. III. Role of conversion enzyme (kininase II) in protaminase activity of plasma].
    Blass J; Detruit H; Aime L; Fiancette JY; Gaillard M; Verriest C; Vicaigne MB; Weiss M
    Pathol Biol (Paris); 1988 Dec; 36(10):1192-8. PubMed ID: 2853323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
    Vernigora AN; Nikishin NN; Gengin MT
    Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical and physiological characteristics of the kininase and angiotensin-converting function of the lungs].
    Gomazkov OA; Trapeznikova SS
    Usp Sovrem Biol; 1978; 86(2):259-68. PubMed ID: 214969
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioregulation of kinins: kallikreins, kininogens, and kininases.
    Bhoola KD; Figueroa CD; Worthy K
    Pharmacol Rev; 1992 Mar; 44(1):1-80. PubMed ID: 1313585
    [No Abstract]   [Full Text] [Related]  

  • 6. Kininases and converting enzyme in human placenta.
    Litorowicz A; Małofiejew M
    Biochem Pharmacol; 1978; 27(24):2829-34. PubMed ID: 32889
    [No Abstract]   [Full Text] [Related]  

  • 7. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
    Husain A; Li M; Graham RM
    Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinins, receptors, kininases and inhibitors--where did they lead us?
    Erdös EG; Marcic BM
    Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ethanol, diazepam, and reserpine on the activity of angiotensin-converting enzyme and carboxypeptidase in normal state and during stress].
    Vernigora AN; Nikishin NN; Gengin MT
    Vopr Med Khim; 1996; 42(2):127-30. PubMed ID: 9148596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of immobilized carboxypeptidase with a natural inhibitor from human blood plasma].
    Trapeznikova SS; Gontar' ID
    Vopr Med Khim; 1977; (6):840-4. PubMed ID: 595489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV; Gomazkov OA
    Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
    [No Abstract]   [Full Text] [Related]  

  • 15. Some old and some new ideas on kinin metabolism.
    Erdös EG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S20-4. PubMed ID: 1697356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.
    Dales NA; Gould AE; Brown JA; Calderwood EF; Guan B; Minor CA; Gavin JM; Hales P; Kaushik VK; Stewart M; Tummino PJ; Vickers CS; Ocain TD; Patane MA
    J Am Chem Soc; 2002 Oct; 124(40):11852-3. PubMed ID: 12358520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kininase inhibition by glucagon.
    Olsen UB
    Acta Endocrinol (Copenh); 1978 Mar; 87(3):552-6. PubMed ID: 580144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of angiotensin I convertase activity in the serum of the rat].
    Dudkiewicz J; Suska T; Tautt J
    Acta Pol Pharm; 1989; 46(4):391-5. PubMed ID: 2561433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Distribution of renal kininases in relation to the kallikrein-bradykinin system and water excretion.
    Ward PE; Mills IH
    J Endocrinol; 1975 Nov; 67(2):60P. PubMed ID: 173783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.